高危患者血管内动脉瘤修复:系统综述与Meta分析
本系统综述与Meta分析检索MEDLINE、EMBASE、CINAHL和CENTRAL,纳入高危患者接受EVAR的研究,评估围手术期死亡、总死亡及动脉瘤相关死亡。18 416例高危患者EVAR围手术期死亡率为3%(95%CI 2.3-4%),随时间显著下降;EVAR围手术期死亡率低于开放修复(OR 0.64;95%CI 0.45-0.92),但总死亡(HR 1.06;95%CI 0.76-1.49)和动脉瘤相关死亡(HR 0.57;95%CI 0.21-1.55)无显著差异。与无干预相比,EVAR总死亡无显著差异(HR 0.42;95%CI 0.14-1.26),但动脉瘤相关死亡显著更低(HR 0.30;95%CI 0.14-0.63)。
要点
- 高危患者EVAR围手术期死亡率为3%(95%CI 2.3-4%),随发表年份和研究中位时间点显著下降。
- EVAR围手术期死亡率低于开放修复,但总死亡和动脉瘤相关死亡无显著差异。
- 与无干预相比,EVAR动脉瘤相关死亡显著更低,但总死亡无显著差异。
核心结论
- 高危患者EVAR围手术期死亡率随时间改善。
- EVAR动脉瘤相关死亡低于无干预,但EVAR可能不带来总生存获益。
研究设计与样本
- 系统综述与Meta分析,检索MEDLINE、EMBASE、CINAHL和CENTRAL,方案注册于PROSPERO(CRD42021287207),按PRISMA 2020报告。
- 采用OR或HR及95%CI计算合并估计,使用Mantel-Haenszel或逆方差法;用混合效应Meta回归分析EVAR围手术期死亡率随时间变化;采用GRADE框架评级证据确定性。
主要发现
- 18 416例高危患者接受EVAR的围手术期死亡率为3%(95%CI 2.3-4%),随发表年份(p=.003)和研究的中位时间点(p=.023)显著下降。
- 高危患者EVAR围手术期死亡率显著低于开放修复(OR 0.64;95%CI 0.45-0.92),但总死亡(HR 1.06;95%CI 0.76-1.49)和动脉瘤相关死亡(HR 0.57;95%CI 0.21-1.55)无显著差异。
- 高危患者EVAR与无干预相比总死亡无显著差异(HR 0.42;95%CI 0.14-1.26),但动脉瘤相关死亡显著更低(HR 0.30;95%CI 0.14-0.63)。
- 高危患者EVAR的围手术期死亡率高于正常风险患者(OR 2.33;95%CI 1.75-3.10),总死亡也更高(HR 3.50;95%CI 2.55-4.80)。
- EVAR对比开放手术或无干预的证据确定性为极低,高危对比正常风险患者的证据确定性为低。
关键数值与推荐
- 高危患者EVAR围手术期死亡率为3%(95%CI 2.3-4%)。
- EVAR vs 开放修复:围手术期死亡OR 0.64(95%CI 0.45-0.92);总死亡HR 1.06(95%CI 0.76-1.49);动脉瘤相关死亡HR 0.57(95%CI 0.21-1.55)。
- EVAR vs 无干预:总死亡HR 0.42(95%CI 0.14-1.26);动脉瘤相关死亡HR 0.30(95%CI 0.14-0.63)。
- 高危 vs 正常风险患者接受EVAR:围手术期死亡OR 2.33(95%CI 1.75-3.10);总死亡HR 3.50(95%CI 2.55-4.80)。
临床怎么用
- 原文未据此给出推荐。
局限性
- EVAR对比开放手术或无干预的证据确定性为极低。
- 高危对比正常风险患者的证据确定性为低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate outcomes of endovascular aneurysm repair (EVAR) in high risk patients. METHODS: Bibliographic sources (MEDLINE, EMBASE, CINAHL, and CENTRAL) were searched using combinations of thesaurus and free text terms. The review protocol was registered in PROSPERO (CRD42021287207) and reported according to PRISMA 2020. Pooled estimates were calculated using odds ratio (OR) or hazard ratio (HR) and 95% confidence interval (CI) applying the Mantel-Haenszel or inverse variance method. EVAR peri-operative mortality in high risk patients over time was examined with mixed effects meta-regression. The GRADE framework was used to rate the certainty of evidence. RESULTS: The pooled peri-operative mortality in 18 416 high risk patients who underwent EVAR was 3% (95% CI 2.3 - 4%) and has significantly reduced over time (year of publication p = .003; median study point p = .023). The peri-operative mortality was significantly lower in high risk patients treated with EVAR compared with open repair (OR 0.64; 95% CI 0.45 - 0.92), but no significant difference was found in overall (HR 1.06; 95% CI 0.76 - 1.49) or aneurysm related mortality (HR 0.57; 95% CI 0.21 - 1.55). No significant difference was found in overall mortality between high risk patients treated with EVAR vs. no intervention (HR 0.42; 95% CI 0.14 - 1.26), but the aneurysm related mortality was significantly lower in the former (HR 0.30; 95% CI 0.14 - 0.63). The peri-operative mortality was higher in high risk than normal risk patients treated with EVAR (OR 2.33; 95% CI 1.75 - 3.10), as was the overall mortality (HR 3.50; 95% CI 2.55 - 4.80). The certainty of evidence was very low for EVAR vs. open surgery or no intervention and low for high vs. normal risk patients. CONCLUSION: The EVAR peri-operative mortality in high risk patients has improved over time. Even though the aneurysm related mortality of EVAR is lower compared with no intervention, EVAR may confer no overall survival benefit.
引用
- Kontopodis N, Galanakis N, Charalambous S, et al. Editor's Choice - Endovascular Aneurysm Repair in High Risk Patients: A Systematic Review and Meta-Analysis. Eur J Vasc Endovasc Surg. 2022. PMID: 35872342. doi:10.1016/j.ejvs.2022.07.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。